Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress.
Saved in:
| Title: | Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress. |
|---|---|
| Authors: | Knowles JK; Department of Neurology, Division of Child Neurology, Stanford University School of Medicine, Stanford, California, USA., Helbig I; Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Epilepsy NeuroGenetics Initiative, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Neurology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Institute of Clinical Molecular Biology, University of Kiel, Kiel, Germany.; Department of Neuropediatrics, University Medical Center Schleswig-Holstein, Kiel, Germany., Metcalf CS; Department of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, Utah, USA., Lubbers LS; Citizens United for Research in Epilepsy, Chicago, Illinois, USA., Isom LL; Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan, USA., Demarest S; Department of Pediatrics and Neurology, University of Colorado, School of Medicine, Aurora, Colorado, USA., Goldberg EM; Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Epilepsy NeuroGenetics Initiative, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Neurology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA., George AL Jr; Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Lerche H; Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany., Weckhuysen S; Division of Neurology, University Hospital Antwerp, Antwerp, Belgium.; Applied and Translational Neurogenomics Group, Vlaams Instituut voor Biotechnologie Center for Molecular Neurology, Antwerp, Belgium.; Translational Neurosciences, Faculty of Medicine and Health Science, University of Antwerp, Antwerp, Belgium.; μNEURO Research Center of Excellence, University of Antwerp, Antwerp, Belgium., Whittemore V; Division of Neuroscience, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Rockville, Maryland, USA., Berkovic SF; Epilepsy Research Centre, Department of Medicine, Austin Health, University of Melbourne, Melbourne, Victoria, Australia., Lowenstein DH; Department of Neurology, University of California, San Francisco, San Francisco, California, USA. |
| Source: | Epilepsia [Epilepsia] 2022 Oct; Vol. 63 (10), pp. 2461-2475. Date of Electronic Publication: 2022 Jul 17. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1528-1167 |
|---|---|
| DOI: | 10.1111/epi.17332 |
